According to AnaptysBio's latest financial reports the company's current revenue (TTM) is $17.15 M. In 2022 the company made a revenue of $10.28 M a decrease over the years 2021 revenue that were of $63.17 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $17.15 M | 66.78% |
2022 | $10.28 M | -83.72% |
2021 | $63.17 M | -15.77% |
2020 | $75 M | 837.5% |
2019 | $8 M | 60% |
2018 | $5 M | -50% |
2017 | $10 M | -40.06% |
2016 | $16.68 M | -5.05% |
2015 | $17.57 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |